A prospective, multicentre, open-label single-arm exploratory study to evaluate efficacy and safety of saroglitazar on hypertriglyceridemia in hiv associated lipodystrophy

HIGHLIGHTS

• who: Alka Deshpande and collaborators from the Bandra West, Mumbai, India, Clinical R and, Cadila Healthcare Limited, Zydus Research Centre, SarkhejBavla NHNo. A, Moriaya, Ahmedabad, Gujarat, India have published the research: A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0146222]. January 20, 2016 of May/23,/2015
• what: Objective This study was designed to explore the efficacy and safety of saroglitazar mg on hypertriglyceridemia in patients with associated Methods Accepted: December . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.